Disclosures for "Failed Mechanical Thrombectomy: prevalence, etiology and predictors")
-
Dr. Ali has nothing to disclose.
-
Dr. Lajthia has nothing to disclose.
-
Dr. Almallouhi has nothing to disclose.
-
Dr. Essibayi has nothing to disclose.
-
Dr. Bass has nothing to disclose.
-
Dr. Neyens has nothing to disclose.
-
Dr. Anadani has nothing to disclose.
-
The institution of Mr. Chalhoub has received research support from National Institute for Drug Abuse.
-
Kimberly Kicielinski has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Kimberly Kicielinski has received research support from Penumbra.
-
Jonathan Lena has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker Neurovascular.
-
Guilherme Porto has nothing to disclose.
-
Dr. Sattur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Penumbra. Dr. Sattur has stock in CLPT.
-
Alejandro Spiotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Alejandro Spiotta has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for IschemaView. Alejandro Spiotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Terumo. Alejandro Spiotta has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker. The institution of Alejandro Spiotta has received research support from Penumbra. The institution of Alejandro Spiotta has received research support from Medtronic. The institution of Alejandro Spiotta has received research support from Stryker.
-
Sami Al Kasab has nothing to disclose.